Zusammenfassung
Die akute Pankreatitis manifestiert sich in ca. 15% der Fälle als schwere Verlaufsform und ist durch (peri)pankreatische Nekrosen und (Multi)organversagen sowie eine beträchtliche Mortalität gekennzeichnet. Entsprechend wird die moderne interdisziplinäre Therapie in Abhängigkeit vom Schweregrad anhand von Klinik, Laborparametern und Bildgebung adaptiert. Die Patienten sind intensivmedizinisch zu überwachen, unter besonderer Beachtung von Flüssigkeitsbedarf, Nierenfunktion und Atmung. Prophylaktische Antibiotika zur Vorbeugung von Infektionskomplikationen werden an zahlreichen Zentren verabreicht, werden aber immer noch kontrovers diskutiert. Hintergrund ist die ungünstigere Prognose bei Nekroseninfektion, bei der in der Vergangenheit immer die Indikation zur chirurgischen Intervention gestellt wurde. Infizierte Nekrosen lassen sich oft konservativ therapieren; in refraktären Fällen und/oder bei lokalen Komplikationen sind konventionelle chirurgische Verfahren unverändert Standard. Man wird jedoch versuchen, den Operationszeitpunkt bis 4–6 Wochen nach Erkrankungsbeginn hinauszuzögern. Debridementverfahren mit einer postoperativ fortgesetzten Evakuation von Debris und Exsudat sind wegen einer verminderten Relaparotomierate und Morbidität zu bevorzugen (kontinuierliche postoperative Lavage und „closed packing“). Der Stellenwert der an Zentren eingesetzten minimalinvasiven Verfahren (retroperitoneoskopisch oder transgastral-endoskopisch) ist derzeit noch nicht abschließend zu beurteilen.
Abstract
About 15% of patients with acute pancreatitis have a severe course, which is characterized by (peri)pancreatic necrosis, (multi)organ failure, and a substantial mortality rate. Modern interdisciplinary therapy is adapted to the severity of disease according to clinical findings, laboratory parameters, and imaging methods. Patients need intensive care treatment with special attention to fluid replacement, renal function, and ventilation. Antibiotics are used prophylactically in many institutions to prevent infectious complications, although this is still a matter of debate. The rationale for using antibiotics is an adverse outcome in the case of infected necrosis, which used to be an established indication for surgical intervention. However, many cases of infected necrosis can be treated conservatively; in refractory cases and local complications, conventional surgery is still standard therapy, but modern therapeutic concepts aim at postponing surgery until 4–6 weeks after the onset of symptoms. Debridement procedures with postoperative continuous evacuation of debris and exudate are associated with a low rate of relaparotomy and morbidity and are preferred (continuous postoperative lavage and „closed packing“). The clinical role of minimally invasive treatment modalities as practiced by several expert centers (minimally invasive retroperitoneoscopic/ transgastric-endoscopic procedures) cannot be finally assessed yet.
Literatur
Layer P, Kahl M, Keller J, Rosien U (2008) Akute Pankreatitis. In: Layer P, Rosien U (Hrsg) Praktische Gastroenterologie. Elsevier, München
Soran A, Chelluri L, Lee KKW et al (2000) Outcome and quality of life of patients with acute pancreatitis requiring intensive care. J Surg Res 91: 89–94
Sempere L, Martinez J, de Madaria E et al (2008) Obesity and fat distribution imply a greater systemic inflammatory response and a worse prognosis in acute pancreatitis. Pancreatology 8: 257–264
Werner J, Hartwig W, Uhl W et al (2003) Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 3: 115–127
Banks PA, Freeman ML (2006) Practice guidelines in acute pancreatitis. Am J Gastroenterol 101: 2379–2400
Mofidi R, Duff MD, Wigmore SJ et al (2006) Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 93: 738–744
Wu BU, Johannes R, Sun X et al (2008) The early prediction of mortality in acute pancreatitis: a large population-based study. Gut 57: 1698–1703
Arvanitakis M, Delhaye M, De Maertelaere V et al (2004) Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. J Gastroenterol 126: 715–723
Liu CL, Fan ST, Lo CM et al (2005) Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol 3: 1238–1244
Siriwardena AK, Mason JM, Balachandra S et al (2007) Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut 56: 1439–1444
Uhl W, Büchler MW, Malfertheiner P et al (1999) A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 45: 97–104
Johnson CD, Kingsnorth AN, Imrie CW et al (2001) Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 48: 62–69
Furuya T, Komatsu M, Takahashi K et al (2002) Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases. Ther Apher 6: 454–458
Tenner S (2004) Initial management of acute pancreatitis: critical issues during the first 72 hours. Am J Gastroenterol 99: 2489–2494
Lerch MM (2004) No more intravenous procaine for pancreatitis pain? Digestion 69: 2–4
Vera-Portocarrero LP, Xie JY, Kowal J et al (2006) Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. J Gastroenterol 130: 2155–2164
Petrov MS, van Santvoort HC, Besselink MG et al (2008) Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg 143: 1111–1117
Besselink MG, van Santvoort HC, Buskens E et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371: 651–659 (Epub 2008, Feb 14)
Manes G, Uomo I, Menchise A et al (2006) Timing of antibiotic prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol 101: 1348–1353
Bassi C, Larvin M, Villatoro E (2003) Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev: CD002941
Bai Y, Gao J, Zou DW, Li ZS (2008) Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol 103: 104–110
Golub R, Siddiqi F, Pohl D (1998) Role of antibiotics in acute pancreatitis: A meta-analysis. J Gastrointest Surg 2: 496–503
Hartwig W, Marksan SM, Foitzik T et al (2002) Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg 6: 481–487
Andersson B, Olin H, Eckerwall G, Andersson R (2006) Severe acute pancreatitis–outcome following a primarily non-surgical regime. Pancreatology 6: 5536–5341 (Epub 2006, Nov 10)
Sivasankar A, Kannan DG, Ravichandran P et al (2006) Outcome of severe acute pancreatitis: is there a role for conservative management of infected pancreatic necrosis? Hepatobiliary Pancreat Dis Int 5: 599–604
Gloor B, Müller CA, Worni M et al (2001) Late mortality in patients with severe acute pancreatitis. Br J Surg 88: 975–979
Büchler MW, Gloor B, Müller CA et al (2000) Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 232: 619–626
Tsiotos GG, Luque-de LE, Sarr MG (1998) Long-term outcome of necrotizing pancreatitis treated by necrosectomy. Br J Surg 85: 1650–1653
Besselink MG, de Bruijn MT et al (2006) Surgical intervention in patients with necrotizing pancreatitis. Br J Surg 93: 593–599
Andersson B, Olin H, Eckerwall G, Andersson R (2006) Severe acute pancreatitis–outcome following a primarily non-surgical regime. Pancreatology 6: 536–541 (Epub 2006, Nov 10)
Sivasankar A, Kannan DG, Ravichandran P et al (2006) Outcome of severe acute pancreatitis: is there a role for conservative management of infected pancreatic necrosis? Hepatobiliary Pancreat Dis Int 5: 599–604
Connor S, Raraty MG, Neoptolemos JP et al (2006) Does infected pancreatic necrosis require immediate or emergency debridement? Pancreas 33: 128–134
Bradley EL, Allen K (1991) A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg 161: 19–24
Uhl W, Warshaw A, Imrie C et al (2002) IAP Guidelines for the surgical management of acute pancreatitis. Pancreatology 2: 565–573
UK Working Party on Acute Pancreatitis (2005) UK guidelines for the management of acute pancreatitis. Gut 54 (Suppl 3): 1–9
Hackert T, Hartwig W, Fritz S et al (2009) Ischemic acute pancreatitis: clinical features of 11 patients and review of the literature. Am J Surg 197: 450–454
Hartwig W, Marksan SM, Foitzik T et al (2002) Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg 6: 481–487
Besselink MG, Verwer TJ, Schoenmaeckers EJ et al (2007) Timing of surgical intervention in necrotizing pancreatitis. Arch Surg 142: 1194–1201
Rodriguez JR, Razo AO, Targarona J et al (2008) Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg 247: 294–299
Mier J, Leon EL, Castillo A et al (1997) Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 173: 71–75
Bradley EL (1991) Operative management of acute pancreatitis: ventral open packing. Hepatogastroenterology 38: 134–138
Sarr MG, Nagorney DM, Mucha PJ et al (1991) Acute necrotizing pancreatitis: management by planned, staged pancreatic necrosectomy/debridement and delayed primary wound closure over drains. Br J Surg 78: 576–581
Beger HG, Büchler M, Bittner R et al (1988) Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg 75: 207–212
Fernandez-del Castillo C, Rattner DW, Makary MA et al (1998) Debridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 228: 676–684
Heinrich S, Schafer M, Rousson V, Clavien PA (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243: 154–168
Werner J, Feuerbach S, Uhl W, Büchler MW (2005) Management of acute pancreatitis: from surgery to interventional intensive care. Gut 54: 426–436
van Ruler O, Mahler CW, Boer KR et al (2007) Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 298: 865–872
Carter CR, McKay CJ, Imrie CW (2000) Percutaneous necrosectomy and sinus tract endoscopy in the management of infected pancreatic necrosis: an initial experience. Ann Surg 232: 175–180
Connor S, Ghaneh P, Raraty M et al (2003) Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg 20: 270–277
Escourrou J, Shehab H, Buscail L et al (2008) Peroral transgastric/transduodenal necrosectomy: success in the treatment of infected pancreatic necrosis. Ann Surg 248: 1074–1080
van Santvoort HC, Besselink MG, Bollen TL et al (2007) Case-matched comparison of the retroperitoneal approach with laparotomy for necrotizing pancreatitis. World J Surg 31: 1635–1642
Besselink MG, van Santvoort HC, Nieuwenhuijs VB et al (2006) Minimally invasive ‚step-up approach‘ versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868]. BMC Surg 6: 6
Voermans RP, Veldkamp MC, Rauws EA et al (2007) Endoscopic transmural debridement of symptomatic organized pancreatic necrosis (with videos). Gastrointest Endosc 66: 909–916
Papachristou GI, Takahashi N, Chahal P et al (2007) Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg 245: 943–951
Seifert H, Biermer M, Schmitt W et al (2009) Transluminal endoscopic necrosectomy after acute pancreatitis: a multicenter study with long-term follow-up (the GEPARD Study). Gut (Epub ahead of print)
Petrov MS, van Santvoort HC, Besselink MG et al (2008) Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg 247: 250–257
Liu CL, Fan ST, Lo CM et al (2005) Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol 3: 1238–1244
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Additional information
U. Rosien und W. Hartwig haben gleichen Anteil an dieser Arbeit und teilen sich die Erstautorenschaft.
Rights and permissions
About this article
Cite this article
Rosien, U., Hartwig, W., Keller, J. et al. Moderne interdisziplinäre Therapie der nekrotisierenden Pankreatitis. Gastroenterologe 4, 411–418 (2009). https://doi.org/10.1007/s11377-009-0292-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-009-0292-4
Schlüsselwörter
- Nekrotisierende Pankreatitis
- Antibiotikaprophylaxe
- Infizierte Nekrose
- Kontinuierliche chirurgische Nekrosendrainage
- Interventionelle Nekrosendrainage